2026-05-29
[Press Release] SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia's National Central Hospital
SCL Group and Hanaro Medical Foundation signed an MOU with Indonesia's RSCM to cooperate on advanced medical services, precision diagnostics, and AI solutions.
![[Press Release] SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia's National Central Hospital](/uploads/hanaromf/224269176366/2ebb762b7879f89d.jpg)
[Press Release] SCL Group and Hanaro Medical Foundation Integrate K-Health into Indonesia’s National Central Hospital

Hello. This is Hanaro Medical Foundation.
SCL Group and Hanaro Medical Foundation have signed a Memorandum of Understanding (MOU) with RSUP Cipto Mangunkusumo (RSCM), Indonesia’s National Central Hospital, for cooperation in advanced medical services and diagnostics. RSCM is the representative national hospital of Indonesia, and this partnership marks the first collaborative case between a Korean medical institution and Indonesia in the field of diagnostic medicine.
Under this agreement, both institutions plan to promote priority cooperation and exchanges in mid-to-long-term overseas business areas, including: △Precision diagnostics such as early multi-cancer screening and genetic testing △AI-based early diagnosis solutions △Joint utilization of medical equipment such as MRI and CT △K-Healthcare, LAB, and IT platforms.
In particular, as there is high local demand for services focused on early diagnosis and preventive medicine, various business expansions such as health screenings and data-based medical services are expected in the future.
This collaboration is anticipated to serve as a significant milestone for entering the Southeast Asian market and expanding our global medical network.
📰 Hanaro Medical Foundation in the Press 📰
#HanaroMedicalFoundation #HealthScreening #Indonesia #IndonesiaNationalCentralHospital #RSCM #KHealthcare
Frequently Asked Questions
Where did SCL Group and Hanaro Medical Foundation sign a business agreement?
Yes, they signed a business agreement with RSCM, Indonesia's representative national central hospital. This collaboration is highly significant as it is the first partnership between a Korean medical institution and a diagnostic medicine field.
What are the main areas of cooperation with the Indonesian National Central Hospital?
The main areas of cooperation are precision diagnostics, including multi-cancer early screening and genetic testing, and AI-based early diagnosis solutions. Additionally, they plan to jointly utilize medical equipment such as MRI and CT, and prioritize cooperation in mid-to-long-term overseas business areas such as K-healthcare and IT platforms.
What medical services are particularly in high demand in Indonesia?
There is the highest demand for medical services focused on early diagnosis and preventive medicine. Based on this local demand, various business expansions, including health check-ups and data-based medical services, are expected in the future.
What are the expected effects of signing this business agreement?
The biggest expected effects are entry into the Southeast Asian healthcare market and expansion of the global medical network. By expanding business areas based on diagnostic tests and health check-ups, they plan to secure a forward base for medical exports and actively target the Southeast Asian market.